CN104159588A - 用于调节胃肠细菌以促进健康的方法和组合物 - Google Patents

用于调节胃肠细菌以促进健康的方法和组合物 Download PDF

Info

Publication number
CN104159588A
CN104159588A CN201280064861.5A CN201280064861A CN104159588A CN 104159588 A CN104159588 A CN 104159588A CN 201280064861 A CN201280064861 A CN 201280064861A CN 104159588 A CN104159588 A CN 104159588A
Authority
CN
China
Prior art keywords
compositions
approximately
day
amount
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280064861.5A
Other languages
English (en)
Chinese (zh)
Inventor
T.W.博伊勒奥
J.布鲁
R.S.梅农
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Mills Inc
Original Assignee
General Mills Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Mills Inc filed Critical General Mills Inc
Publication of CN104159588A publication Critical patent/CN104159588A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/126—Snacks or the like obtained by binding, shaping or compacting together cereal grains or cereal pieces, e.g. cereal bars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201280064861.5A 2011-11-04 2012-11-01 用于调节胃肠细菌以促进健康的方法和组合物 Pending CN104159588A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161555800P 2011-11-04 2011-11-04
US61/555,800 2011-11-04
PCT/US2012/063008 WO2013067146A1 (en) 2011-11-04 2012-11-01 Methods and compositions for modulating gastrointestinal bacteria to promote health

Publications (1)

Publication Number Publication Date
CN104159588A true CN104159588A (zh) 2014-11-19

Family

ID=48192757

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280064861.5A Pending CN104159588A (zh) 2011-11-04 2012-11-01 用于调节胃肠细菌以促进健康的方法和组合物

Country Status (11)

Country Link
US (1) US20150209383A1 (enExample)
EP (1) EP2773357A4 (enExample)
JP (1) JP2014532710A (enExample)
KR (1) KR20140093252A (enExample)
CN (1) CN104159588A (enExample)
AU (1) AU2012332491A1 (enExample)
BR (1) BR112014010660A2 (enExample)
CA (1) CA2854398A1 (enExample)
IN (1) IN2014CN04055A (enExample)
MX (1) MX2014005433A (enExample)
WO (1) WO2013067146A1 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109219656A (zh) * 2016-09-06 2019-01-15 深圳华大生命科学研究院 长栖粪杆菌（Faecalibacterium longum）及其应用
CN109998112A (zh) * 2017-12-22 2019-07-12 奥地利商艾尔柏有限公司 红蝽杆菌纲促进肠道健康的用途
WO2019227418A1 (zh) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 一种组合物及其应用
CN113544255A (zh) * 2018-11-30 2021-10-22 西班牙高等科研理事会 用于预防和治疗肥胖及其并发症的粪考拉杆菌
CN114786690A (zh) * 2019-10-07 2022-07-22 谢尔塔治疗公司 治疗性药物组合物
CN116322720A (zh) * 2020-03-13 2023-06-23 菲特碧奥米克斯股份有限公司 用于改善人类健康和运动表现的益生菌组合物

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201312713D0 (en) * 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
EP3283087A4 (en) * 2015-04-14 2019-03-13 Ubiome Inc. METHOD AND SYSTEM FOR MICROBIOMEDIVED DIAGNOSTICS AND THERAPEUTICS FOR DISEASES OF THE ENDOCRINE SYSTEM
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
GB201519088D0 (en) * 2015-10-28 2015-12-09 Metabogen Ab The use of bacteria formulations
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN106994136A (zh) 2016-01-26 2017-08-01 富士胶片株式会社 肠内细菌数量抑制剂、食品、及药品
EP3431090A4 (en) * 2016-03-14 2020-04-15 B Food Science Co., Ltd. PROLIFERATIVE AGENT FOR FAECALIBACTERIUM BACTERIA
WO2018220237A1 (en) 2017-06-02 2018-12-06 Goodgut Sl Grape skin for use in the treatment of dysbiosis
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
EP3466417A1 (en) * 2017-10-04 2019-04-10 Sorbonne Université Compounds for the prevention and treatment of glucose intolerance related conditions and obesity
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
WO2019158546A1 (en) * 2018-02-14 2019-08-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Polydextrose for the treatment of inflammatory diseases
WO2019216815A1 (en) * 2018-05-09 2019-11-14 Carbiotix Ab Method for measuring and improving gut health
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
KR102174095B1 (ko) * 2019-12-11 2020-11-05 주식회사 에이치이엠 신규한 엔테로코커스 패시움 hem 200 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물
JP2021168651A (ja) * 2020-04-16 2021-10-28 サンスター株式会社 フィーカリバクテリウム属細菌増殖用組成物、酪酸産生増加用組成物、及び腸内環境改善用組成物
CN117119907A (zh) * 2021-05-06 2023-11-24 雀巢产品有限公司 使用肌醇、赤藓糖醇或山梨糖醇中的至少一种来增强普拉梭菌生长的组合物和方法
CA3238788A1 (en) 2021-11-22 2023-05-25 Eric Michael Schott Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059333A2 (en) * 2002-01-15 2003-07-24 Danisco A/S Stimulation of the immune system with polydextrose
CN101677603A (zh) * 2007-05-23 2010-03-24 泰特&莱尔组分美国公司 包含可缓慢消化或耐消化的寡糖组合物的可食用组合物
CN102439048A (zh) * 2009-05-07 2012-05-02 泰莱配料法国有限公司 组合物及制备α-(1,2)-支化的α-(1,6)葡聚寡糖的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0394655A (ja) * 1989-09-06 1991-04-19 Otsuka Pharmaceut Co Ltd 栄養補給用組成物
JP4328473B2 (ja) * 2001-04-09 2009-09-09 雪印乳業株式会社 肥満予防改善飲食品
JP2003334025A (ja) * 2002-05-15 2003-11-25 Toyo Shinyaku:Kk 健康食品
EP1530642B1 (en) * 2002-08-06 2009-12-30 Danisco A/S Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions
GB0302872D0 (en) * 2003-02-10 2003-03-12 Univ Liverpool Treatment of inflammatory bowel disease
GB0903016D0 (en) * 2009-02-23 2009-04-08 Univ Gent Method for alleviating intestinal problems and novel bacterial strains therefor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059333A2 (en) * 2002-01-15 2003-07-24 Danisco A/S Stimulation of the immune system with polydextrose
CN101677603A (zh) * 2007-05-23 2010-03-24 泰特&莱尔组分美国公司 包含可缓慢消化或耐消化的寡糖组合物的可食用组合物
CN102439048A (zh) * 2009-05-07 2012-05-02 泰莱配料法国有限公司 组合物及制备α-(1,2)-支化的α-(1,6)葡聚寡糖的方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
INE´S MARTÍNEZ: "Diet-Induced Metabolic Improvements in a Hamster Model of Hypercholesterolemia Are Strongly Linked to Alterations of the Gut Microbiota", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》 *
ROBIN F. J. BENUS等: "Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects", 《BRITISH JOURNAL OF NUTRITION》 *
SEEMA HOODA: "454 Pyrosequencing Reveals a Shift in Fecal", 《THE JOURNAL OF NUTRITION》 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109219656A (zh) * 2016-09-06 2019-01-15 深圳华大生命科学研究院 长栖粪杆菌（Faecalibacterium longum）及其应用
CN109998112A (zh) * 2017-12-22 2019-07-12 奥地利商艾尔柏有限公司 红蝽杆菌纲促进肠道健康的用途
CN109998112B (zh) * 2017-12-22 2024-05-14 奥地利商艾尔柏有限公司 红蝽杆菌纲促进肠道健康的用途
WO2019227418A1 (zh) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 一种组合物及其应用
CN112218646A (zh) * 2018-05-31 2021-01-12 深圳华大生命科学研究院 一种组合物及其应用
US11376289B2 (en) 2018-05-31 2022-07-05 Bgi Shenzhen Composition and uses thereof
CN112218646B (zh) * 2018-05-31 2024-06-11 深圳华大生命科学研究院 一种组合物及其应用
CN113544255A (zh) * 2018-11-30 2021-10-22 西班牙高等科研理事会 用于预防和治疗肥胖及其并发症的粪考拉杆菌
CN113544255B (zh) * 2018-11-30 2024-07-30 西班牙高等科研理事会 用于预防和治疗肥胖及其并发症的粪考拉杆菌
CN114786690A (zh) * 2019-10-07 2022-07-22 谢尔塔治疗公司 治疗性药物组合物
CN116322720A (zh) * 2020-03-13 2023-06-23 菲特碧奥米克斯股份有限公司 用于改善人类健康和运动表现的益生菌组合物

Also Published As

Publication number Publication date
CA2854398A1 (en) 2013-05-10
KR20140093252A (ko) 2014-07-25
BR112014010660A2 (pt) 2017-05-09
IN2014CN04055A (enExample) 2015-10-23
EP2773357A1 (en) 2014-09-10
JP2014532710A (ja) 2014-12-08
WO2013067146A1 (en) 2013-05-10
MX2014005433A (es) 2014-08-22
EP2773357A4 (en) 2015-08-26
US20150209383A1 (en) 2015-07-30
AU2012332491A1 (en) 2014-05-29

Similar Documents

Publication Publication Date Title
CN104159588A (zh) 用于调节胃肠细菌以促进健康的方法和组合物
Kristek et al. Oat bran, but not its isolated bioactive β-glucans or polyphenols, have a bifidogenic effect in an in vitro fermentation model of the gut microbiota
JP7280243B2 (ja) 栄養組成物並びに該栄養組成物を用いた飲食品組成物及び調製粉乳
Grootaert et al. Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem
JP7273725B2 (ja) 新規ビフィドバクテリウム属細菌及び当該細菌を含む組成物
CN105451576B (zh) 通过使用来自普雷沃氏菌属的至少一种细菌菌株治疗肥胖、代谢综合征、2型糖尿病、心血管疾病、痴呆、阿尔茨海默病和炎性肠病
CN101674840B (zh) 植物乳杆菌用于增加细菌多样性的用途
JP5932662B2 (ja) 穀物ベースフラクション及びプロバイオティックを含む非発酵組成物、並びにそれらの使用
Fares et al. Nutritional profile and cooking quality of a new functional pasta naturally enriched in phenolic acids, added with β-glucan and Bacillus coagulans GBI-30, 6086
JP6562837B2 (ja) シャルドネ種子製品の治療上の使用
CN106103696B (zh) 新颖的拟干酪乳杆菌菌株
WO2019112053A1 (ja) 新規ビフィドバクテリウム属細菌及び当該細菌を含む組成物
Pei et al. Effect of cooked rice with added fructo-oligosaccharide on faecal microorganisms investigated by in vitro digestion and fermentation
WO2008069102A1 (ja) 炎症性腸疾患予防治療剤
US12491218B2 (en) Prebiotic and probiotic cookie preparation
JP6998193B2 (ja) 新規ビフィドバクテリウム属細菌及び当該細菌を含む組成物
Bouaziz et al. Functional properties of β-glucan extracted from Algerian barley, and its effect on different parameters of overfed rats
BAJWA et al. Impact of galacto-oligosaccharides on prebiotic potential in the intestinal microbiota fermentation and health status in an animal model
Valdés et al. Population dynamics of some relevant intestinal microbial groups in human fecal batch cultures with added fermentable xylooligosaccharides obtained from rice husks
WO2021003073A1 (en) Prebiotic and probiotic cookie preparation
Butorac et al. Shaping the gut microbiota of tumour-induced mice with an innovative mixture of dietary fibres designed for food for oncological medical purpose
US11311478B2 (en) Prebiotic and probiotic cookie preparation
JP7592750B2 (ja) 酪酸菌用プレバイオティクス組成物
Çetin et al. Cholesterol-Lowering Potential of Synbiotic Combination of Inulin and Enterococcus spp. Strains via Bile Salt Deconjugation and EPS Production
Leow Gut Community Response to Wheat Bran and Pinto Bean

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141119

WD01 Invention patent application deemed withdrawn after publication